Acutus Medical Inc. (AFIB) News
Filter AFIB News Items
AFIB News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
AFIB News Highlights
- For AFIB, its 30 day story count is now at 5.
- Over the past 21 days, the trend for AFIB's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest AFIB News From Around the Web
Below are the latest news stories about ACUTUS MEDICAL INC that investors may wish to consider to help them evaluate AFIB as an investment opportunity.
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)CARLSBAD, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on June 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 3 individuals hired by Acutus in May 2023. The equity awards wer |
Acutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Call TranscriptAcutus Medical, Inc. (NASDAQ:AFIB) Q1 2023 Earnings Call Transcript May 11, 2023 Acutus Medical, Inc. beats earnings expectations. Reported EPS is $-0.57, expectations were $-0.69. Operator: Good afternoon and thank you for standing by. Welcome to the Acutus Medical First Quarter 2023 Conference Call. [Operator Instructions] I would now like to hand the conference over […] |
Acutus Medical to Showcase Innovative Cardiac Mapping and Ablation Technologies at HRS 2023CARLSBAD, Calif., May 15, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, is pleased to announce its participation in the upcoming Heart Rhythm Society (HRS) Annual Scientific Sessions in New Orleans, LA from May 19-21, 2023. As an exhibitor at HRS, Acutus Medical will showcase its latest groundbreaking electrophysiology systems and technologies, including AcQMap® |
Q1 2023 Acutus Medical Inc Earnings CallQ1 2023 Acutus Medical Inc Earnings Call |
Acutus Medical Reports First Quarter 2023 Financial ResultsCARLSBAD, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the first quarter of 2023. Recent Highlights: Reported revenue of $4.2 million for the first quarter of 2023, a 13% increase compared to $3.7 million for the same quarter last year.Continued improvement in financial performance with year-over-year |
Acutus Medical to Announce First Quarter 2023 Financial ResultsCARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2023 financial results on Thursday, May 11, 2023. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent h |
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 ResultsCARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023 in addition to the release of the RECOVER AF study data (published online in EP Europace)1. Preliminary Unaudited First Quarter 2023 ResultsThe Company expects first quarter 2023 revenue in the range |
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation TherapyCARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced results from the RECOVER AF study. The study, published online in EP Europace, found that patients who received AcQMap-guided ablations for retreatment achieved better outcomes compared to those who underwent traditional anatomical retreatment strategies.1-3 Moreover, the s |
Acutus Medical, Inc. (NASDAQ:AFIB) Might Not Be As Mispriced As It Looks After Plunging 25%To the annoyance of some shareholders, Acutus Medical, Inc. ( NASDAQ:AFIB ) shares are down a considerable 25% in the... |
Acutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call TranscriptAcutus Medical, Inc. (NASDAQ:AFIB) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Thank you for standing by. Welcome to Acutus Medical’s Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen-only mode. After the speaker presentation, there will be a question-and-answer session. . I would now like […] |